Anticancer Therapies – Multimedia

Traditionally, cancer treatment has revolved around chemotherapy, radiation and surgery. But thanks to groundbreaking immune checkpoint blockade research led by Jim Allison, Ph.D., we have a new way to treat cancer: immunotherapy. Rather than treating the cancer directly, immunotherapy trains the immune system to attack cancer.

Just when you thought you’d got to grips with the idea of big data, a whole new set of buzzwords comes along: artificial intelligence, machine learning, deep learning, structured and unstructured data. But for the pharmaceutical industry right now these are more than just buzzwords, they are the promise of a new era of productivity.

This infographic explores the various types of immunotherapy, their pros and cons and looks at some recent success stories in the field.

Complete “Sample-to-Result” Highly Automated NGS and qPCR Workflow for Clinical Diagnostics.

Here we describe a platform of T cell activation bioassays for the development of CD3 bispecific antibodies and engineered T cell immunotherapies.

Professor Peter Johnson - Professor of Medical Oncology, University of Southampton and Chief Clinician for Cancer Research UK.

In this seminar Tom Dubensky talks us through the use of listeria monocytogenes for the development of cancer immunotherapy.

Jeffrey S. Weber, M.D., Ph.D., discusses the cancer immunity cycle and the importance of antigen release and presentation to maximize the potential of immunotherapies.

Download this infographic to discover what makes CD47 an attractive target for the development of novel therapeutics.

In this list, we pay homage to 9 of the most incredible images we’ve seen from the field of cancer research.